Bristlecone Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
15,260
-9,609
| -39% | -$663K | 0.09% | 126 |
|
|
2025
Q1 | $1.73M | Buy |
24,869
+12,576
| +102% | +$873K | 0.14% | 122 |
|
|
2024
Q4 | $1.06M | Buy |
12,293
+2,395
| +24% | +$206K | 0.08% | 144 |
|
|
2024
Q3 | $1.18M | Buy |
9,898
+725
| +8% | +$86.3K | 0.09% | 133 |
|
|
2024
Q2 | $1.31M | Buy |
9,173
+2,000
| +28% | +$285K | 0.11% | 127 |
|
|
2024
Q1 | $921K | Buy |
7,173
+1,761
| +33% | +$226K | 0.08% | 145 |
|
|
2023
Q4 | $560K | Buy |
5,412
+2,605
| +93% | +$269K | 0.06% | 170 |
|
|
2023
Q3 | $255K | Buy |
+2,807
| New | +$255K | 0.03% | 227 |
|